Zealand Pharma (22Z) Ownership - Who Owns Zealand Pharma?
Zealand Pharma (22Z) Ownership Overview
- 17.02% Mutual Funds
- 7.81% ETFs
- 75.17% Public Companies and Individual Investors
The ownership structure of Zealand Pharma (DE:22Z) stock is a mix of institutional, retail, and individual investors. Approximately 24.83% of the company’s stock is owned by Institutional Investors, and 75.17% is owned by Public Companies and Individual Investors.
The ownership structure of Zealand Pharma (DE:22Z) stock is a mix of institutional, retail, and individual investors. Approximately 24.83% of the company’s stock is owned by Institutional Investors, and 75.17% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Europacific Growth Fund | 3,454,693 | Institution | 4.82% | 118,033,041 |
| Vanguard | 2,201,808 | Institution | 3.07% | 75,226,972 |
| Eupac Fund | 1,835,275 | Institution | 2.56% | 62,704,006 |
| Ishares | 1,383,794 | Institution | 1.93% | 47,278,706 |
| Smallcap World Fund Inc | 1,146,460 | Institution | 1.60% | 39,169,952 |
| Vanguard Star Funds | 1,034,768 | Institution | 1.45% | 35,353,883 |
| Vanguard World Fund | 974,798 | Institution | 1.36% | 33,304,948 |
| Fidelity Mt. Vernon Street Trust | 847,318 | Institution | 1.18% | 28,949,467 |
| Vanguard Tax-managed Funds | 691,130 | Institution | 0.97% | 23,613,148 |
| Vanguard International Equity Index Funds | 491,082 | Institution | 0.69% | 16,778,308 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Europacific Growth Fund | 3,454,693 | Institution | 4.82% | 118,033,041 |
| Eupac Fund | 1,835,275 | Institution | 2.56% | 62,704,006 |
| Smallcap World Fund Inc | 1,146,460 | Institution | 1.60% | 39,169,952 |
| Vanguard Star Funds | 1,034,768 | Institution | 1.45% | 35,353,883 |
| Vanguard World Fund | 974,798 | Institution | 1.36% | 33,304,948 |
| Fidelity Mt. Vernon Street Trust | 847,318 | Institution | 1.18% | 28,949,467 |
| Vanguard Tax-managed Funds | 691,130 | Institution | 0.97% | 23,613,148 |
| Vanguard International Equity Index Funds | 491,082 | Institution | 0.69% | 16,778,308 |
| Dfa Investment Dimensions Group Inc | 409,950 | Institution | 0.57% | 14,006,352 |
| Fidelity Select Portfolios | 377,990 | Institution | 0.53% | 12,914,406 |
FAQ
What percentage of Zealand Pharma (DE:22Z) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.83% of Zealand Pharma (DE:22Z) stock is held by institutional investors: 17.02% by mutual funds and 7.81% by ETFs.
What percentage of Zealand Pharma (DE:22Z) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.17% of Zealand Pharma (DE:22Z) stock is held by public companies and individual investors.
Who owns the most shares of Zealand Pharma (DE:22Z)?
EuroPacific Growth Fund owns the most shares of Zealand Pharma (DE:22Z).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.